TEVA PHARMACEUTICALS USA, INC. for TEVA PHARMACEUTICALS USA INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 22, 2013 | $1,570,000 | Replaced |
| 1st Quarter - Amendment | Apr 22, 2013 | $1,570,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Tariff (miscellaneous tariff bills) TAR
Ttemporarily suspend the duty on S-(2-benzothiazolyl)-2-(2-amino-thiazol-4-yl)-2-acetoxyimino thiocetate (Thioester).
Foreign entity interest: Teva Pharmaceuticals, Ltd., as an indirect parent of Teva Pharmaceuticals USA, Inc., has an indirect interest in the issue(s) listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBRA BARRETT | — |
| GRANT ERDEL | — |
| TERRI STEWART | — |
Trade (domestic/foreign) TRD
Trans-Pacific Partnership Trade Agreement
Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, Inc. has an indirect interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBRA BARRETT | — |
| GRANT ERDEL | — |
| TERRI STEWART | — |
Copyright/Patent/Trademark CPT
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, Inc. has an indirect interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN New | L.A., Rep Xavier Becerra (2000-2001) |
| DEBRA BARRETT | — |
| GRANT ERDEL | — |
| ROBERT FALB | — |
| TERRI STEWART | — |
Pharmacy PHA
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives, Plan B
Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, Inc. has an indirect interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | L.A., Rep Xavier Becerra (2000-2001) |
| DEBRA BARRETT | — |
| GRANT ERDEL | — |
| ROBERT FALB | — |
| TERRI STEWART | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.